Raia Drogasil S.A. (RADLY)
OTCMKTS
· Delayed Price · Currency is USD
2.420
-0.390 (-13.88%)
May 16, 2025, 11:24 AM EDT
Raia Drogasil Revenue
Raia Drogasil had revenue of 10.05B BRL in the quarter ending March 31, 2025, with 10.44% growth. This brings the company's revenue in the last twelve months to 39.81B, up 13.29% year-over-year. In the year 2024, Raia Drogasil had annual revenue of 38.86B with 14.40% growth.
Revenue (ttm)
39.81B BRL
Revenue Growth
+13.29%
P/S Ratio
0.66
Revenue / Employee
614.83K BRL
Employees
64,758
Market Cap
4.59B USD
Revenue Chart
* This company reports financials in BRL.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 38.86B | 4.89B | 14.40% |
| Dec 31, 2023 | 33.97B | 4.91B | 16.88% |
| Dec 31, 2022 | 29.07B | 4.94B | 20.48% |
| Dec 31, 2021 | 24.13B | 4.06B | 20.23% |
| Dec 31, 2020 | 20.07B | 2.50B | 14.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| BioStem Technologies | 332.45M |
Raia Drogasil News
- 7 days ago - Raia Drogasil: Valuation Burn Now, Healthy Gains Later - Seeking Alpha
- 2 months ago - Raia Drogasil SA (RADLY) Q4 2024 Earnings Call Highlights: Expansion and Digital Growth Amid ... - GuruFocus
- 5 months ago - Raia Drogasil S.A. goes ex dividend tomorrow - Seeking Alpha
- 7 months ago - Raia Drogasil goes ex dividend tomorrow - Seeking Alpha